Cardiomyopathy‐associated and basic residue mutations in myopalladin alter actin binding, bundling, and structural stability
Protein Science · 2026
DOI: 10.1002/pro.70490 ↗At a glance
Journal article in Protein Science, 2026. Written by Asha Rankoth Arachchige and 8 co-authors. Institution: Department of Chemistry and Biochemistry, Wichita State University, Wichita, Kansas, USA. Major MEDLINE topics: Actins, Cardiomyopathies, Muscle Proteins, Mutation. 63 references. The full text is freely available in PubMed Central. Funded by: U.S. Department of Agriculture, NIGMS NIH HHS, NIAMS NIH HHS.
Abstract (original language)
Myopalladin (MYPN) is a striated muscle‐specific protein essential for sarcomere integrity and actin filament organization. The Ig3 domain of MYPN mediates direct binding and bundling of filamentous actin (F‐actin), and several cardiomyopathy (CM)‐associated mutations cluster within this domain. To elucidate the molecular basis of MYPN‐actin interactions, we performed alanine‐scanning mutagenesis of conserved basic residues and evaluated CM‐linked variants of the Ig3 domain using co‐sedimentation assays. These mutations impaired actin binding and abolished bundling activity, despite preserving secondary structure in most cases. Circular dichroism revealed that the P961L variant adopts a more open, partially unfolded β‐sandwich conformation, distinct from the wild type (WT), which correlates with its aggregation and mislocalization in Drosophila cardiomyocytes. In vivo expression of full‐length WT and mutant MYPN in Drosophila muscle confirmed Z‐disc localization for WT, while R955W and P961L mutants formed aberrant clusters. Biochemical assays demonstrated that MYPN Ig3 promotes actin polymerization and bundling even under non‐polymerizing conditions, and its interaction with actin is electrostatically driven but calcium‐independent. Sedimentation equilibrium analysis confirmed that MYPN Ig3 functions as a monomer, suggesting that bundling arises from dual actin‐binding surfaces rather than from self‐oligomerization. These findings establish the Ig3 domain as a structurally robust, actin‐regulatory module and identify disruption of MYPN–actin interactions as a pathogenic mechanism in CM. Our study provides the first direct evidence linking Ig3 domain mutations to impaired actin dynamics and sarcomere disorganization, offering mechanistic insight into MYPN‐associated cardiomyopathies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry and Biochemistry, Wichita State University, Wichita, Kansas, USA.
- Department of Biochemistry and Molecular Biophysics, Kansas State University, Wichita, Kansas, USA.
ORCID profiles: Michal Zolkiewski, Moriah R Beck
Funding
- U.S. Department of Agriculture
- NIGMS NIH HHS
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of General Medical Sciences
Cite
APA
Arachchige, A. R., Tran, J., Zhao, Z., Dammann, H., Michaelis, A., Kadarla, V. K., Zolkiewski, M., Geisbrecht, E. R., & Beck, M. R. (2026). Cardiomyopathy‐associated and basic residue mutations in myopalladin alter actin binding, bundling, and structural stability. Protein Science. https://doi.org/10.1002/pro.70490
Vancouver
Arachchige AR, Tran J, Zhao Z, Dammann H, Michaelis A, Kadarla VK, et al. Cardiomyopathy‐associated and basic residue mutations in myopalladin alter actin binding, bundling, and structural stability. Protein Science. 2026. doi:10.1002/pro.70490
BibTeX
@article{Arachchige2026,
author = {Arachchige, Asha Rankoth and Tran, Julie and Zhao, Ziwei and Dammann, Hannah and Michaelis, Alia and Kadarla, Vinay K and Zolkiewski, Michal and Geisbrecht, Erika R and Beck, Moriah R},
title = {Cardiomyopathy‐associated and basic residue mutations in myopalladin alter actin binding, bundling, and structural stability},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70490}
}
EUVIMED